Analyst Ratings for BeOne Medicines (ONC)
ONC Rating Summary
ONC Price Target Summary
- Highest: $453.00 (Citi)
- Lowest: $250.00 (Aletheia Capital)
- Average: $396.93
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$396.93 (+24.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$396.93 (+24.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Jefferies | Faisal Khurshid | Upgrade | Buy (Hold) |
380.00 (333.00) |
302.83 (319.93) |
5.65% | Details |
| 5/20/2026 | JPMorgan | Jessica Fye | New Coverage | Overweight (N/A) |
415.00 (N/A) |
293.09 (319.93) |
9.16% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
